Loading cancer entity…
Loading cancer entity…
Clinical trials
10 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02594709 | Multisession Radiosurgery for Optic Nerve Sheath Meningiomas(ONSMsmSRS) | completed | N/A | 56 | Fondazione I.R.C.C.S. Istituto Neurologico Carlo BestaOTHER | 1 | Aug 31, 2026 | clinicaltrials |
| NCT03326388 | Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours(INSPECT) | completed | Phase 1 / Phase 2 | 14 | Great Ormond Street Hospital for Children NHS Foundation TrustOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT02839720 | Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma | completed | Phase 2 | 11 | National Cancer Institute (NCI)NIH | 1 | Dec 6, 2023 | clinicaltrials |
Data updated 23 days agoSource updated Aug 31, 2026source: clinicaltrials
| NCT01800032 |
| PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1) |
| completed |
| — |
| 30 |
| UNC Lineberger Comprehensive Cancer CenterOTHER |
| 1 |
| May 12, 2021 |
| clinicaltrials |